Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by dload7on Oct 09, 2018 10:21am
164 Views
Post# 28765645

RE:From the Financial Post today, Not sure why Vic would make

RE:From the Financial Post today, Not sure why Vic would make
Daredevil1964 wrote:

such a statement, knowing that legalization is just around the corner. There is no mention of supply chain issues from other LPs?
That would have disappointed the clients IMHO.
Financial Post link to article below.


‘Supply chain issues’ contributing to early cannabis shortfall: Aphria CEO

One of Canada’s largest licensed cannabis producers says it will not be able to meet the full demand requested by the provinces by Oct. 17

The CEO of one of Canada’s largest licensed cannabis producers says his company is facing “short-term supply chain issues” and will not be able to meet the full demand requested by the provinces by Oct. 17, the day that cannabis becomes legal for recreational use in Canada.

“I’ve been communicating this (to the provincial regulators) for several months now leading up to Oct. 17. I’ve said all along that if you want X kilos from Aphria, I cannot make that promise until the spring of 2019, so here’s what we can deliver,” Aphria chief executive Vic Neufeld told the Financial Post.

Aphria has supply agreements with all 10 provinces and Yukon. In a Sept. 20 press release, the Leamington Ont.-based producer said that it had “begun shipping initial product orders” to ensure that an “extensive range of products will be available to consumers on Oct. 17.”

CEO of Aphria Inc., Vic Neufeld, stands among rows of cannabis plants in the greenhouse at Aphria Inc. in Leamington, Ontario. Dax Melmer for National Post

But Neufeld’s comments indicate that at least for the next few months ­- in part due to “start-up-type obstacles” that Neufeld says are being encountered across the industry – Aphria will struggle to meet the total amount of product requested by the provinces. “All our products have been allocated between medical and provincial ‘rec’, but even there, we will not be able to supply in the next three months, everything that they want.”

One of the issues standing in the way of the company shipping its finished product to the provinces on time is the delay in getting government-issued excise stamps delivered to Aphria’s facilities, Neufeld said. Under the Cannabis Act, all packaged cannabis products are required to have excise stamps with specific colours, indicating the province or territory in which the product will be sold.




Bullboard Posts